Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

NCT00828204 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen